TLR7 and COVID-19: Given that the marked lung inflammation in the setting of TLR7 dysregulation was reminiscent of the pathophysiology not only of SLE but also of severe viral infections such as COVID-19, we conducted additional hematologic and serologic analyses to assess whether other parameters known to be altered in this infection were similarly affected.